×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Windlas Biotech Limited | 1991.26 | 155.76 | 1950.19 | 7.38 | 1,652 | 26.8 |
| Tarsons Products Limited | 965.26 | 52.59 | 956.77 | 0.99 | 1618 | 35.3 |
| THEMIS MEDICARE LTD. | 948.28 | 5.19 | 938.06 | 0.06 | 1609 | 34.9 |
Windlas Biotech Limited, with Security Code 543329, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 119.9 | 132.7 | 119.7 | 140.7 | 144.7 | 152.6 | 162.2 | 171.2 | 175.1 | 187.0 |
| Expenses | 106.1 | 116.7 | 105.8 | 124.3 | 127.6 | 134.0 | 141.9 | 149.4 | 154.3 | 164.0 |
| Operating Profit | 13.8 | 16.0 | 13.9 | 16.4 | 17.1 | 18.7 | 20.3 | 21.9 | 20.9 | 23.0 |
| OPM % | 11.5% | 12.09% | 11.65% | 11.69% | 11.84% | 12.24% | 12.54% | 12.81% | 11.92% | 12.33% |
| Other Income | 2.9 | 2.6 | 2.2 | 2.3 | 2.6 | 3.2 | 3.2 | 4.4 | 4.1 | 4.8 |
| Interest | 0.4 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 1.1 |
| Depreciation | 2.8 | 2.9 | 3.1 | 3.6 | 3.2 | 3.3 | 3.4 | 3.5 | 6.2 | 6.5 |
| Profit before tax | 13.5 | 15.6 | 12.8 | 15.0 | 16.3 | 18.3 | 19.8 | 22.6 | 18.3 | 20.3 |
| Tax % | 27.6% | 22% | 28.3% | 23.9% | 26.2% | 23.4% | 23.8% | 24.9% | 26.4% | 22.8% |
| Net Profit | 9.8 | 12.2 | 9.2 | 11.4 | 12.1 | 14.0 | 15.1 | 16.9 | 13.5 | 15.7 |
| EPS in Rs | 4.5 | 5.59 | 4.24 | 5.37 | 5.79 | 6.75 | 7.26 | 8.12 | 6.44 | 7.43 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 132.7 | 119.7 | 140.7 | 144.8 | 152.7 | 162.2 | 171.3 | 175.2 | 187.0 | 195.0 |
| Expenses | 116.7 | 105.8 | 124.3 | 127.6 | 134.0 | 141.9 | 149.3 | 154.3 | 164.0 | 170.4 |
| Operating Profit | 16.0 | 13.9 | 16.4 | 17.1 | 18.7 | 20.3 | 22.0 | 20.9 | 23.1 | 24.6 |
| OPM % | 12.1% | 11.6% | 11.7% | 11.8% | 12.2% | 12.5% | 12.8% | 11.9% | 12.3% | 12.6% |
| Other Income | 2.6 | 2.2 | 2.3 | 2.6 | 3.2 | 3.2 | 4.4 | 4.1 | 4.8 | 4.1 |
| Interest | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 1.1 | 1.5 |
| Depreciation | 2.9 | 3.1 | 3.6 | 3.2 | 3.3 | 3.4 | 3.5 | 6.2 | 6.5 | 6.9 |
| Profit before tax | 15.6 | 12.8 | 15.0 | 16.3 | 18.3 | 19.8 | 22.6 | 18.3 | 20.3 | 20.3 |
| Tax % | 22% | 28.3% | 23.9% | 26.2% | 23.4% | 23.8% | 24.9% | 26.4% | 22.8% | 23.4% |
| Net Profit | 12.2 | 9.2 | 11.4 | 12.1 | 14.0 | 15.1 | 17.0 | 13.5 | 15.7 | 15.6 |
| EPS in Rs | 5 | 4 | 5 | 5 | 6 | 7 | 8 | 6 | 7 | 7 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | 14% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 44% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 46% |
| 1 Year: | 44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 23% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 46% |
| 1 Year: | 44% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|